Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.
2.

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.

Singh S, Amin AV, Loke YK.

Arch Intern Med. 2009 Feb 9;169(3):219-29. doi: 10.1001/archinternmed.2008.550. Review.

PMID:
19204211
3.
4.

Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

Yang IA, Clarke MS, Sim EH, Fong KM.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD002991. doi: 10.1002/14651858.CD002991.pub3. Review.

PMID:
22786484
5.

Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?

Festic E, Scanlon PD.

Am J Respir Crit Care Med. 2015 Jan 15;191(2):141-8. doi: 10.1164/rccm.201409-1654PP. Review.

6.

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.

Kew KM, Seniukovich A.

Cochrane Database Syst Rev. 2014 Mar 10;(3):CD010115. doi: 10.1002/14651858.CD010115.pub2. Review.

PMID:
24615270
7.

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus inhaled corticosteroids alone for chronic obstructive pulmonary disease.

Nannini LJ, Poole P, Milan SJ, Kesterton A.

Cochrane Database Syst Rev. 2013 Aug 30;(8):CD006826. doi: 10.1002/14651858.CD006826.pub2. Review.

PMID:
23990350
8.

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Drummond MB, Dasenbrook EC, Pitz MW, Murphy DJ, Fan E.

JAMA. 2008 Nov 26;300(20):2407-16. doi: 10.1001/jama.2008.717. Review. Erratum in: JAMA. 2009 Mar 11;301(10):1024.

9.

Chronic obstructive pulmonary disease treated with inhaled medium- or high-dose corticosteroids: a prospective and randomized study focusing on clinical efficacy and the risk of pneumonia.

Cheng SL, Su KC, Wang HC, Perng DW, Yang PC.

Drug Des Devel Ther. 2014 May 28;8:601-7. doi: 10.2147/DDDT.S63100. eCollection 2014 May 28.

10.

Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease.

Finney L, Berry M, Singanayagam A, Elkin SL, Johnston SL, Mallia P.

Lancet Respir Med. 2014 Nov;2(11):919-32. doi: 10.1016/S2213-2600(14)70169-9. Epub 2014 Sep 17. Review.

PMID:
25240963
11.

Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.

Kew KM, Dias S, Cates CJ.

Cochrane Database Syst Rev. 2014 Mar 26;(3):CD010844. doi: 10.1002/14651858.CD010844.pub2. Review.

PMID:
24671923
12.
13.
14.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Karner C, Cates CJ, Evans DJ.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD007033. doi: 10.1002/14651858.CD007033.pub3. Review.

PMID:
22161409
15.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Evans DJ, Karner C, Cates CJ.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007033. doi: 10.1002/14651858.CD007033.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD007033.

PMID:
21975759
16.

Inhaled corticosteroids and incident pneumonia in patients with asthma: Systematic review and meta-analysis.

Bansal V, Mangi MA, Johnson MM, Festic E.

Acta Med Acad. 2015;44(2):135-58. doi: 10.5644/ama2006-124.141. Review.

17.

Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis.

Puhan MA, Bachmann LM, Kleijnen J, Ter Riet G, Kessels AG.

BMC Med. 2009 Jan 14;7:2. doi: 10.1186/1741-7015-7-2.

18.

Inhaled corticosteroids and the increased risk of pneumonia.

Marzoratti L, Iannella HA, Waterer GW.

Ther Adv Respir Dis. 2013 Aug;7(4):225-34. doi: 10.1177/1753465813480550. Epub 2013 Feb 27. Review.

PMID:
23445751
19.

Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

Yang IA, Fong KM, Sim EH, Black PN, Lasserson TJ.

Cochrane Database Syst Rev. 2007 Apr 18;(2):CD002991. Review. Update in: Cochrane Database Syst Rev. 2012;7:CD002991.

PMID:
17443520
20.

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis.

DiSantostefano RL, Li H, Hinds D, Galkin DV, Rubin DB.

Int J Chron Obstruct Pulmon Dis. 2014 May 7;9:457-68. doi: 10.2147/COPD.S60498. eCollection 2014 May 7.

Supplemental Content

Support Center